Prudential Financial Inc Assembly Biosciences, Inc. Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$1.7 - $20.52 $4,760 - $57,456	2,800 Added 16.49%	19,780 $32,000
Q2 2022 Aug 15, 2022	SELL	$1.35 - $2.29 $151,131 - $256,363	-111,949 Reduced 86.83%	16,980 $36,000
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $47,486 - $85,148	-3,149 Reduced 2.38%	128,929 $2.12 Million
Q2 2020 Aug 12, 2020	BUY	$14.57 - $23.96 $13,244 - $21,779	909 Added 0.69%	132,078 $3.08 Million
Q1 2020 May 12, 2020	BUY	$10.27 - $21.23 $108,790 - $224,889	10,593 Added 8.79%	131,169 $1.95 Million
Q4 2019 Feb 11, 2020	SELL	$8.36 - $23.81 $907,260 - $2.58 Million	-108,524 Reduced 47.37%	120,576 $2.47 Million
Q3 2019 Nov 13, 2019	BUY	$9.83 - $14.82 $808,330 - $1.22 Million	82,231 Added 55.99%	229,100 $2.25 Million
Q2 2019 Aug 08, 2019	SELL	$12.9 - $20.8 $113,520 - $183,040	-8,800 Reduced 5.65%	146,869 $0
Q1 2019 May 15, 2019	BUY	$17.7 - $24.93 $2.76 Million - $3.88 Million	155,669 New	155,669 $0

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.